Show simple item record

dc.contributor.authorRoque, D.M.
dc.contributor.authorSantin, A.D.
dc.date.accessioned2019-09-19T18:35:47Z
dc.date.available2019-09-19T18:35:47Z
dc.date.issued2017
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85004009693&doi=10.1080%2f1744666X.2017.1266938&partnerID=40&md5=1aeb32ddd8a98f22f9ed0dbba79e68d7
dc.identifier.urihttp://hdl.handle.net/10713/10977
dc.description.urihttps://doi.org/10.1080/1744666X.2017.1266938en_US
dc.language.isoen_USen_US
dc.publisherTaylor and Francis Ltden_US
dc.relation.ispartofExpert Review of Clinical Immunology
dc.subjectimmune checkpoint blockadeen_US
dc.subjectmutational phenotypeen_US
dc.subjectUterine canceren_US
dc.titleUterine cancer, mutational phenotype, and the era of immune checkpoint blockadeen_US
dc.typeArticleen_US
dc.identifier.doi10.1080/1744666X.2017.1266938
dc.identifier.pmid27905822


This item appears in the following Collection(s)

Show simple item record